findmyKOL

Patrick Wen, MD

Enriched profile

Director, Neuro-Oncology Division, Brigham and Women's Hospital; Director, Center for Neuro-Oncology, Dana-Farber Cancer Institute; Professor of Neurology, Harvard Medical School · Dana-Farber Cancer Institute

ORCID↗NPINone on file
✓ Full profile
RegionNot on fileSpecialtyMedical OncologyFocusGlioma Diagnosis and Treatment+4
Active KOLLatest publication2026Online presenceverified 2026PaymentsNot attributedNIH funding1990–2015Why? →

Patrick Wen is Director, Neuro-Oncology Division, Brigham and Women's Hospital; Director, Center for Neuro-Oncology, Dana-Farber Cancer Institute; Professor of Neurology, Harvard Medical School at Dana-Farber Cancer Institute. OpenAlex indexes 1,915 publications with 89,244 citations (h-index 146); ClinicalTrials.gov lists 25 registered studies with this person as an investigator. Clarivate lists Patrick Wen as a Highly Cited Researcher (Cross-Field, 2018-2019, 2023-2024).

Data verified 25 Aug 2026

Overview

Updated 14 Oct 2026

Patrick Y. Wen is Director, Neuro-Oncology Division, Brigham and Women's Hospital at Dana-Farber Cancer Institute / Brigham and Women's Hospital / Harvard Medical School (Boston, MA). The public record shows 1,915 publications with 89,244 citations (h-index 146), centered on Glioma Diagnosis and Treatment, Brain Metastases and Treatment, Cancer, Hypoxia, and Metabolism. It also documents an investigator role on 25 registered clinical trials, 4 NIH-funded awards (1990–2015).

  • Most recent indexed publication: 2026 · Nature medicine
  • Top research focus: Glioma Diagnosis and Treatment
  • 25 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Neuro-Oncology / Glioma19 trialsGlioma11 trialsAstrocytoma9 trialsSarcoma8 trialsGliosarcoma8 trialsComa8 trialsOligodendroglioma7 trialsBrain Neoplasms3 trialsCentral Nervous System Neoplasms3 trialsNervous System Neoplasms3 trialsMeningioma2 trialsHemangiopericytoma1 trialLung Cancer (NSCLC/SCLC)1 trialNeoplasm Metastasis1 trialSmall Cell Lung Carcinoma1 trial

Research focus

OpenAlex concept fingerprint
Glioma Diagnosis and TreatmentBrain Metastases and TreatmentCancer, Hypoxia, and MetabolismRadiomics and Machine Learning in Medical ImagingNeuroblastoma Research and Treatments

Drugs & molecules

across trials, industry payments and publications
TemozolomideClinical trials8Industry payments—Publications4BevacizumabClinical trials3Industry payments—Publications2NivolumabClinical trials2Industry payments—Publications2IpilimumabClinical trials1Industry payments—Publications2AbemaciclibClinical trials1Industry payments—Publications1PembrolizumabClinical trials1Industry payments—Publications1VorasidenibClinical trials1Industry payments—Publications1CelecoxibClinical trials2Industry payments—Publications—ImatinibClinical trials2Industry payments—Publications—ThalidomideClinical trials2Industry payments—Publications—131I-TM601Clinical trials1Industry payments—Publications—AdV-tkClinical trials1Industry payments—Publications—

Works with

trial sponsors and companies reporting payments
Dana-Farber Cancer InstituteClinical trials8Industry payments—Patrick Y. Wen, MDClinical trials6Industry payments—National Cancer Institute (NCI)Clinical trials4Industry payments—Alliance for Clinical Trials in OncologyClinical trials1Industry payments—Angiochem IncClinical trials1Industry payments—AstraZenecaClinical trials1Industry payments—Candel Therapeutics, Inc.Clinical trials1Industry payments—Patrick Wen, MDClinical trials1Industry payments—Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsClinical trials1Industry payments—TransMolecularClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
1,915publications

Distinct works indexed by OpenAlex, matched via ORCID; 58 in PubMed.

89,244citations

Total citations across indexed works.

146h-index

Hirsch index (OpenAlex). i10-index 674.

Clinical & industry

trials, payments and federal funding
25clinical trials

Investigator role on registered studies.

View trials ↓
—payment companies

Not shown. No U.S. clinical registration on file.

4NIH grants · 1990–2015

Federally funded research awards.

View funding ↓

This is a research profile, built on the published record. There's no U.S. clinical registration (NPI) on file, so facts that hang off one (clinical specialty, industry payments) aren't shown. We'd rather leave a gap than guess. Why? →

Contact

An office address from a public listing. This research profile has no federal registry record to draw from.

Office address

60 Fenwood Road, 1st Floor, Hale Building for Transformative Medicine, Boston, MA 02115

From the cited public source.Collected 14 Oct 2026.View source ↗

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 25 registered studies on ClinicalTrials.gov. The most recent:

All 25 trial records: search, sort and filter.Explore →

Industry payments

Not shown. This person has no U.S. clinical registration (NPI) on file, so we can't reliably tie industry payments reported to CMS to them. We'd rather leave a gap than guess. Why? →

NIH funding

Updated 14 Oct 2026

4 NIH research awards on record, funded 1990–2015 per NIH RePORTER. The latest:

All 19 award records: search, sort and filter.Explore →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

All 58 publications: search, sort and filter.Explore →

Most-cited works

by citation count (OpenAlex)
  1. 01
    Malignant Gliomas in Adults
    4,244 citations2008
    doi.org ↗
  2. 02
    Updated Response Assessment Criteria for High-Grade Gliomas: Response Assessment in Neuro-Oncology Working Group
    3,830 citations2010
    doi.org ↗
  3. 03
    Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma
    2,445 citations2009
    doi.org ↗
  4. 04
    AZD2171, a Pan-VEGF Receptor Tyrosine Kinase Inhibitor, Normalizes Tumor Vasculature and Alleviates Edema in Glioblastoma Patients
    1,765 citations2007
    doi.org ↗
  5. 05
    Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
    1,433 citations2018
    doi.org ↗
All 1,915 cited works: search, sort and filter.Explore →

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Timothy F. Cloughesy519David A. Reardon442Tracy T. Batchelor328Keith L. Ligon326Benjamin M. Ellingson254Eudocia Q. Lee248Minesh P. Mehta217Isabel Arrillaga‐Romany214Lakshmi Nayak199John de Groot199Nicholas Butowski196Jan Drappatz195Brian M. Alexander190Andrew B. Lassman166Martin J. van den Bent161Joshua E. Allen156Rameen Beroukhim153Rohinton S. Tarapore151Elizabeth R. Gerstner151Burt Nabors146Pascale Varlet141Manmeet S. Ahluwalia138Yazmín Odia132Raymond Y. Huang131Ingo K. Mellinghoff126Alona Muzikansky125Yoshie Umemura125Nathalie Y.R. Agar124David Schiff123Nicole Shonka123Ashley Sumrall118Andrew Chi116Rebecca A. Harrison115Michael D. Prados115Sharon L. Gardner114Sylwia A. Stopka113Michael Weller112Andrew D. Norden112Michael S. Regan111Wenya Linda Bi110

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/patrick-wen-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Patrick-Y-Wen-38800436

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    curetoday.com/view/how-fda-approved-modeyso-works-to-treat-glioma

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →curetoday.com ↗
  • Other

    onclive.com/view/fda-approval-insights-dordaviprone-in-h3k27m-mutated-diffuse-midline-glioma-with-patrick-y-wen-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
  • X / Twitter

    x.com/DanaFarberNews/status/1970178782364303773

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
  • YouTube

    youtube.com/watch

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Medical College of St. Bartholomew's Hospital, University of London

    1981
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →physiciandirectory.brighamandwomens.org ↗

Editorial & leadership roles

journal and society appointments
  • Former Editor-in-Chief

    Neuro-Oncology

    2014
    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →pmc.ncbi.nlm.nih.gov ↗
  • Executive Editor

    Neuro-Oncology (Oxford Academic / Society for Neuro-Oncology journal)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →academic.oup.com ↗
  • Former President

    Society for Neuro-Oncology (SNO)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
  • Co-PI / Principal Investigator

    NCI-supported Adult Brain Tumor Consortium

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
  • Co-chair

    National Cancer Institute Brain Malignancy Steering Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
  • Member

    Response Assessment in Neuro-Oncology (RANO) Working Group Steering Committee

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗
  • Co-chair

    Agents Selection Committee, GBM AGILE international platform trial

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ascopost.com ↗

Highly Cited Researcher

Clarivate's annual list, by award category and year
  • Cross-Field
    2018201920232024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →clarivate.com ↗

Secondary affiliations

appointments beyond the home institution
  • Member

    Science Advisory Board, CNS Pharmaceuticals

    2020
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →biospace.com ↗
  • Scientific Advisor

    Candel Therapeutics

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →candeltx.com ↗
  • Course Director

    Harvard Medical School Professional, Corporate, and Continuing Education

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →learn.hms.harvard.edu ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.